TXG Deferred Revenue

10X Genomics Inc Class A · Deferred Revenue

TXG logo

TXG Deferred Revenue

Latest reported$23.90M
TXG FY Deferred Revenue ($1.83M → $23.90M)
High-resolution chart · PNG

TXG deferred revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

10X Genomics Inc Class A Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
23,902,000
20,658,000
13,150,000
7,867,000
5,340,000
6,199,000
4,601,000
2,776,000
1,827,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.